Vistin Pharma ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	95.84	-	58.52	-12.02	32
Depreciation & Amortization	-	-	17.35	12.28	10.61
Change in Receivables	-28.25	-	12.14	-20.81	-12.76
Changes in Inventories	-5.47	-	3.28	-40.54	-11.12
Changes in Other Operating Activities	-6.62	-	-0.69	44.57	-5.05
Operating Cash Flow	55.5	-	90.59	-10.51	13.68
Capital Expenditures	-	-	-17.9	-64.29	-31.94
Other Investing Activities	0.4	-	0.22	0.03	0.27
Investing Cash Flow	0.4	-	-17.68	-64.26	-31.68
Short-Term Debt Issued	-	-	-45.14	45.14	-
Net Short-Term Debt Issued (Repaid)	-	-	-45.14	45.14	-
Long-Term Debt Repaid	-0.88	-	-0.9	-2.59	-0.84
Net Long-Term Debt Issued (Repaid)	-0.88	-	-0.9	-2.59	-0.84
Common Dividends Paid	-	-	-	-	-22.17
Other Financing Activities	-1.81	-	-2.1	-2.09	-0.29
Financing Cash Flow	-2.69	-	-48.14	40.46	-23.3
Net Cash Flow	53.21	-	24.77	-34.31	-41.29
Free Cash Flow	55.5	0	72.69	-74.8	-18.26
FCF Margin	12.27%	0.00%	16.58%	-24.54%	-6.55%
Free Cash Flow Per Share	1.25	-	1.64	-1.69	-0.41
Levered Free Cash Flow	439.32	62.75	1.58	-10.15	-13.46
Unlevered Free Cash Flow	440.21	66.53	55.48	-55.39	3.16